Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Zaltrap |
|---|---|
| Manufacturer | SANOFI AVENTIS |
| Prescription required | Yes |
Zaltrap 25mg/ml Injection,1vial x 4ml(ziv-aflibercept) (ZIV AFLIBERCEPT)
ZIV AFLIBERCEPT
Description
Zaltrap 25mg/ml Injection,1vial x 4ml(ziv-aflibercept) (ZIV AFLIBERCEPT) is a medicine catalog record in the MediPriceHub database. Active ingredient: ZIV AFLIBERCEPT. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: SANOFI AVENTIS. Therapeutic category: Medicine Library > Oncology Medicines > Colorectal Cancer Medicines. Pack information: 100 / 4 (25 / ) / 1. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.How to Use
Use ZIV AFLIBERCEPT under the supervision of a qualified healthcare professional. It should be prepared and administered only by trained healthcare professionals in a setting appropriate for injectable or infusion medicines. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: ZIV AFLIBERCEPT. Pack size: 100 / 4 (25 / ) / 1. Pack unit: box. Manufacturer: SANOFI AVENTIS. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Colorectal Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Esta información es solo orientativa. Consulta a un profesional sanitario antes de usar cualquier medicamento.